Cargando…
Should we treat pyrexia? And how do we do it?
The concept of pyrexia as a protective physiological response to aid in host defence has been challenged with the awareness of the severe metabolic stress induced by pyrexia. The host response to pyrexia varies, however, according to the disease profile and severity and, as such, the management of p...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047044/ https://www.ncbi.nlm.nih.gov/pubmed/27716372 http://dx.doi.org/10.1186/s13054-016-1467-2 |
_version_ | 1782457384470315008 |
---|---|
author | Doyle, James F. Schortgen, Frédérique |
author_facet | Doyle, James F. Schortgen, Frédérique |
author_sort | Doyle, James F. |
collection | PubMed |
description | The concept of pyrexia as a protective physiological response to aid in host defence has been challenged with the awareness of the severe metabolic stress induced by pyrexia. The host response to pyrexia varies, however, according to the disease profile and severity and, as such, the management of pyrexia should differ; for example, temperature control is safe and effective in septic shock but remains controversial in sepsis. From the reported findings discussed in this review, treating pyrexia appears to be beneficial in septic shock, out of hospital cardiac arrest and acute brain injury. Multiple therapeutic options are available for managing pyrexia, with precise targeted temperature management now possible. Notably, the use of pharmacotherapy versus surface cooling has not been shown to be advantageous. The importance of avoiding hypothermia in any treatment strategy is not to be understated. Whilst a great deal of progress has been made regarding optimal temperature management in recent years, further studies will be needed to determine which patients would benefit the most from control of pyrexia and by which means this should be implemented. This narrative review is part of a series on the pathophysiology and management of pyrexia. |
format | Online Article Text |
id | pubmed-5047044 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50470442016-10-06 Should we treat pyrexia? And how do we do it? Doyle, James F. Schortgen, Frédérique Crit Care Review The concept of pyrexia as a protective physiological response to aid in host defence has been challenged with the awareness of the severe metabolic stress induced by pyrexia. The host response to pyrexia varies, however, according to the disease profile and severity and, as such, the management of pyrexia should differ; for example, temperature control is safe and effective in septic shock but remains controversial in sepsis. From the reported findings discussed in this review, treating pyrexia appears to be beneficial in septic shock, out of hospital cardiac arrest and acute brain injury. Multiple therapeutic options are available for managing pyrexia, with precise targeted temperature management now possible. Notably, the use of pharmacotherapy versus surface cooling has not been shown to be advantageous. The importance of avoiding hypothermia in any treatment strategy is not to be understated. Whilst a great deal of progress has been made regarding optimal temperature management in recent years, further studies will be needed to determine which patients would benefit the most from control of pyrexia and by which means this should be implemented. This narrative review is part of a series on the pathophysiology and management of pyrexia. BioMed Central 2016-10-03 /pmc/articles/PMC5047044/ /pubmed/27716372 http://dx.doi.org/10.1186/s13054-016-1467-2 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Doyle, James F. Schortgen, Frédérique Should we treat pyrexia? And how do we do it? |
title | Should we treat pyrexia? And how do we do it? |
title_full | Should we treat pyrexia? And how do we do it? |
title_fullStr | Should we treat pyrexia? And how do we do it? |
title_full_unstemmed | Should we treat pyrexia? And how do we do it? |
title_short | Should we treat pyrexia? And how do we do it? |
title_sort | should we treat pyrexia? and how do we do it? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047044/ https://www.ncbi.nlm.nih.gov/pubmed/27716372 http://dx.doi.org/10.1186/s13054-016-1467-2 |
work_keys_str_mv | AT doylejamesf shouldwetreatpyrexiaandhowdowedoit AT schortgenfrederique shouldwetreatpyrexiaandhowdowedoit |